ReviewDiabetology & metabolic syndrome2026

Empagliflozin and its impact on hepatic and metabolic outcomes in patients with type 2 diabetes and NAFLD: a systematic review and meta-analysis.

Khadeeja Ali Hamzah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.